Molina Healthcare, Inc. key statistics and ratios
In fiscal 2025, Molina Healthcare, Inc. had return on equity of 11.0%, an operating margin of 1.7%, debt equal to 92.6% of equity and a current ratio of 1.69. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | 12.8% | 10.3% | 10.8% | 9.7% | 9.1% | 13.3% | 13.7% | 12.8% | 14.6% | 15.0% | 15.9% | 15.3% | 13.1% | 12.6% |
| Operating margin | 1.4% | 2.6% | 3.0% | 0.7% | 2.1% | 2.0% | 2.7% | 1.7% | −2.8% | 6.0% | 6.2% | 5.6% | 3.7% | 3.7% | 4.6% | 4.2% | 1.7% | 0.4% |
| Net margin | 0.8% | 1.3% | 0.5% | 0.2% | 0.8% | 0.6% | 1.0% | 0.3% | −2.6% | 3.7% | 4.4% | 3.5% | 2.4% | 2.5% | 3.2% | 2.9% | 1.0% | −0.1% |
| Free-cash-flow margin | — | — | — | — | — | 9.8% | 7.0% | 2.8% | 3.6% | −1.8% | 2.2% | 9.4% | 7.4% | 2.1% | 4.6% | 1.3% | −1.4% | 0.5% |
| Return on equity | 5.7% | 8.7% | 2.8% | 1.3% | 6.3% | 6.5% | 11.1% | 3.2% | −34.3% | 47.4% | 40.9% | 33.2% | 27.9% | 28.3% | 30.4% | 27.1% | 11.0% | −1.2% |
| Return on assets | — | 3.6% | 1.3% | 0.5% | 2.2% | 1.7% | 2.6% | 0.7% | −6.4% | 9.0% | 10.6% | 8.2% | 6.1% | 6.5% | 8.0% | 7.7% | 3.0% | −0.3% |
| Asset turnover | — | 2.71 | 2.87 | 3.30 | 2.68 | 2.60 | 2.58 | 2.54 | 2.50 | 2.42 | 2.41 | 2.38 | 2.55 | 2.61 | 2.50 | 2.66 | 2.91 | 2.83 |
| Current ratio | — | 1.70 | 1.74 | 1.63 | 1.58 | 1.47 | 1.39 | 1.31 | 1.35 | 1.52 | 1.83 | 1.59 | 1.43 | 1.47 | 1.54 | 1.62 | 1.69 | 1.69 |
| Debt to equity | 0.0% | 22.8% | 28.9% | 35.1% | 82.5% | 84.4% | 103.3% | 99.8% | 162.2% | 88.5% | 64.4% | 102.6% | 83.7% | 74.2% | 52.2% | 65.6% | 92.6% | 90.8% |
| Interest cover (operating income ÷ interest) | 3.8x | 6.8x | 8.8x | 2.5x | 2.6x | 3.4x | 5.9x | 3.0x | n/m | 9.8x | 12.0x | 10.6x | 8.5x | 10.7x | 14.4x | 14.5x | 4.1x | 0.8x |
| Effective tax rate | 19.1% | 38.6% | 35.7% | 45.0% | 44.4% | 54.1% | 55.6% | 74.6% | — | 29.2% | 24.2% | 30.0% | 24.7% | 25.5% | 25.5% | 25.8% | 19.9% | — |
| Capital spending as % of revenue | — | — | — | — | — | 1.2% | 0.9% | 1.0% | 0.4% | 0.2% | 0.3% | 0.4% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
| Free cash flow ÷ net income | — | — | — | — | — | >999% | 694.4% | 955.8% | — | −48.7% | 51.2% | 271.0% | 309.9% | 86.1% | 144.6% | 46.1% | −134.7% | — |
| Dividends and buybacks ÷ free cash flow | — | — | — | — | — | 0.0% | 0.0% | — | 0.0% | — | 12.5% | 33.2% | 6.3% | 58.7% | 0.0% | 183.8% | — | 0.0% |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 14.2% | 15.0% | 14.0% | 12.5% | 10.9% | 14.1% | 13.2% | 12.3% |
| Operating margin | 3.6% | 3.9% | 3.3% | 1.2% | −1.4% | 0.8% | 1.3% | 1.0% |
| Net margin | 2.4% | 2.7% | 2.2% | 0.7% | −1.4% | 0.1% | 0.6% | 0.3% |
| Free-cash-flow margin | −2.2% | 1.5% | −3.0% | −1.4% | −2.6% | 9.8% | −3.0% | −1.8% |
| Current ratio | 1.62 | 1.63 | 1.66 | 1.68 | 1.69 | 1.63 | 1.68 | 1.69 |
| Debt to equity | 65.0% | 82.9% | 73.3% | 87.4% | 92.6% | 92.3% | 90.4% | 90.8% |
Moat
Weak moat
How hard Molina Healthcare's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 8 / 20
Net income has been a median 5.9% of total assets over 10 years.
- Pricing power 8 / 20
Gross margin has been a median 14.4%, moving by 2.5 percentage points (standard deviation) across 10 years.
- Durability 0 / 20
Operating margin has been a median 3.8%; its worst year was -1.5%.
- Cash conversion 9 / 20
Free cash flow was positive in 8 of 10 years, at a median 2.2% of revenue.
- Discipline 20 / 20
The diluted share count fell 13.1% over five years; stock-based pay has been a median 0.2% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (44 before it).
Compare with peers
- Oscar Health, Inc. statistics
- Humana statistics
- Elevance Health statistics
- Centene Corporation statistics
- Alignment Healthcare, Inc. statistics
Head to head: MOH vs OSCRHUM vs MOHELV vs MOHALHC vs MOH
More: Managed Health Care stocks compared, Health Care sector, rankings of US companies